MicroRNA and Cancer

MicroRNAs (miRNAs) are short, non-coding RNA molecules, typically 20–24 nucleotides in length, that play a crucial role in regulating gene expression across nearly all biological pathways in mammals. Their involvement in cancer has been increasingly recognized through studies in cell cultures and animal models. miRNAs regulate several critical cancer-related processes, including DNA damage response, cell cycle regulation, and apoptosis.

Emerging evidence supports their clinical relevance, with miRNAs being explored and implemented as diagnostic and prognostic biomarkers, aiding in patient stratification. Moreover, they hold potential as therapeutic agents and targets, paving the way for innovative strategies in personalized cancer treatment.

 

    Related Conference of MicroRNA and Cancer

    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Aix-en-Provence, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    MicroRNA and Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in